Should women at high risk of breast cancer have screening magnetic resonance imaging (MRI)?

Breast

Volumn 16, Issue 1, 2007, Pages 2-4

  Houssami, Nehmat ^a   Wilson, Robin ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN RECEPTOR;

BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ECHOGRAPHY; EDITORIAL; EVIDENCE BASED MEDICINE; FAMILY HISTORY; FEMALE; GENE EXPRESSION PROFILING; GENE MUTATION; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HUMAN; INFORMED CONSENT; INHERITANCE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASS SCREENING; MASTECTOMY; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; PATIENT DECISION MAKING; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH SERVICE; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

EID: 33846621508     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2006.12.001     Document Type: Editorial

References (20)

1. National Collaborating Centre for Primary Care & National Institute for Health and Clinical Excellence. Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. July 2006.
2. Houssami N., Cuzick J., and Dixon J.M. The prevention, detection and management of breast cancer. Med J Australia 184 5 (2006) 230-234
3. Liberman L. Breast cancer screening with MRI-what are the data for patients at high risk?. N Engl J Med 351 (2004) 497-500
4. Irwig L., Houssami N., and van Vliet C. New technologies in screening for breast cancer: a systematic review of their accuracy. Br J Cancer 90 (2004) 2118-2122
5. Leach M.O., Boggis C.R., Dixon A.K., et al., (MARIBS study group). Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365 (2005) 1769-1778
6. Kriege M., Brekelmans C.T.M., Boetes C., et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351 (2004) 427-437
7. Warner E., Plewes D.B., Hill K., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. J Am Med Assoc 292 (2004) 1317-1325
8. Morris E.A., Liberman L., Ballon D.J., et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181 (2003) 619-626
9. Podo F., Sardanelli F., Canese R., et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 21 (2002) 115-124
10. Tilanus-Linthorst M.M.A., Obdeijn I.M.M., Bartels K.C.M., de Koning H.J., and Oudkerk M. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 63 (2000) 53-60
11. Stoutjesdijk M.J., Boetes C., Jager G.J., et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 93 (2001) 1095-1102
12. Kuhl C.K., Schmutzler R.K., Leutner C.C., et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215 (2000) 267-279
13. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. JCO 23 (2005) 8469-8476
14. Hamilton L.J., Evans A.J., Wilson A.R.M., et al. Breast imaging findings in women with BRCA1 and BRCA2 associated breast carcinoma. Clin Radiol 59 (2004) 895-902
15. Elmore J.G., Armstrong K., Lehman C.D., and Fletcher S.W. Screening for breast cancer. J Am Med Assoc 293 (2005) 1245-1256
16. Irwig L., Houssami N., Armstrong B., and Glasziou P. How should we evaluate new screening tests for breast cancer?. Br Med J 332 (2006) 678-679
17. Hillman B.J. Do we need randomized controlled trials to evaluate the clinical impact of breast MR imaging?. Magn Reson Imaging Clin N Am 14 (2006) 403-409
18. Kriege M., Brekelmans C.T.M., Peterse H., et al. Tumour characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Res Treat (2006) 10.1007/s10549-006-9341-6
19. Sims A.H., Ong K.R., Clarke R.B., and Howell A. Exploiting the potential of gene expression profiling: is it ready for the clinic?. Breast Cancer Res 8 (2006) 214 10.1186/bcr1605
20. Nelson H.D., Hoyt-Huffman L., Fu R., and Harris E.L. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the US Preventive Services Task Force. Ann Intern Med 143 (2005) 362-379